Skip to main content

Table 1 Immunohistochemistry score of P-cadherin in each histological subtype

From: Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for P-cadherin targeted therapy: a retrospective cohort study

A: Intensity score (IS)

Histologic type

 

Intensity score (%)

n

0

1

2

3

Clear cell

34

18 (52.9)

13 (38.2)

3 (8.8)

0 (0)

Endometrioid

30

1 (3.3)

8 (26.7)

16 (53.3)

5 (16.7)

Mucinous

23

5 (21.7)

7 (30.4)

10 (43.5)

1 (4.4)

Serous

75

7 (9.3)

14 (18.7)

44 (58.7)

10 (13.3)

All patients

162

31 (19.1)

42 (25.9)

73 (45.1)

16 (9.9)

B: Positive percent score (PPS)

Histologic type

 

Positive percentage score (%)

n

0

1

2

3

Clear cell

34

18 (52.9)

6 (17.6)

6 (17.6)

4 (11.8)

Endometrioid

30

1 (3.3)

7 (23.3)

2 (6.7)

20 (66.7)

Mucinous

23

5 (21.7)

3 (13.0)

4 (17.4)

11 (47.8)

Serous

75

7 (9.3)

6 (8.0)

9 (12.0)

53 (70.7)

All patients

162

31 (19.1)

22 (13.5)

21 (13.0)

88 (54.3)

C: P-cadherin score (Sum of IS and PPS)

Histologic type

  

Total score (%)

 

n

Low

High

Clear cell

 

34

30 (88.2)

4 (11.8)

Endometrioid

 

30

9 (30.0)

21 (70.0)

Mucinous

 

23

12 (52.2)

11 (47.8)

Serous

 

75

16 (21.3)

59 (78.7)

All patients

 

162

67 (41.4)

95 (58.6)

  1. Immunohistochemistry score of P-cadherin in each histological subtype. a: intensity score, b: positive percentage score, c: P-cadherin score